Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Hurle

Showing results (51-60 of 183) with videos related to

Pageof 19
Sort By:
Urologic Oncology|December 3, 2020
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failureRodolfo Hurle, Roberto Contieri, Paolo Casale, et al.
European Urology Focus|December 4, 2020
Multi-institutional Retrospective Validation and Comparison of the Simplified PADUA REnal Nephrometry System for the Prediction of Surgical Success of Robot-assisted Partial NephrectomyPietro Diana, Giovanni Lughezzani, Alessandro Uleri, et al.
Science Translational Medicine|January 7, 2021
Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancerBianca Oresta, Chiara Pozzi, Daniele Braga, et al.
Diagnostic Pathology|January 22, 2016
Usefulness of pT1 substaging in papillary urothelial bladder carcinomaCarlo Patriarca, Rodolfo Hurle, Marco Moschini, et al.
Therapeutic Advances in Urology|April 2, 2016
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidenceMassimo Lazzeri, Rodolfo Hurle, Paolo Casale, et al.
Urologic Oncology|June 29, 2021
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysisPier Paolo Avolio, Giovanni Lughezzani, Marco Paciotti, et al.
European Urology Focus|October 18, 2020
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective StudyGiovanni Lughezzani, Davide Maffei, Alberto Saita, et al.
The Journal of Urology|September 30, 2014
Olfactory system of highly trained dogs detects prostate cancer in urine samplesGianluigi Taverna, Lorenzo Tidu, Fabio Grizzi, et al.
World Journal of Urology|January 10, 2022
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional studyVittorio Fasulo, Nicolò Maria Buffi, Federica Regis, et al.
Minerva Urology and Nephrology|September 2, 2025
The current role of photodynamic diagnosis (PDD) in the management of non-muscle invasive bladder cancer: the Italian Society of Urology (SIU) Position PaperFrancesco Soria, Andrea Mari, Marco Moschini, et al.
Pageof 19

Showing results (51-60 of 183) with videos related to

Sort By:
Pageof 19
Urologic Oncology|December 3, 2020
Midterm follow-up (3 years) confirms and extends short-term results of intravesical gemcitabine as bladder-preserving treatment for non-muscle-invasive bladder cancer after BCG failureRodolfo Hurle, Roberto Contieri, Paolo Casale, et al.
European Urology Focus|December 4, 2020
Multi-institutional Retrospective Validation and Comparison of the Simplified PADUA REnal Nephrometry System for the Prediction of Surgical Success of Robot-assisted Partial NephrectomyPietro Diana, Giovanni Lughezzani, Alessandro Uleri, et al.
Science Translational Medicine|January 7, 2021
Mitochondrial metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancerBianca Oresta, Chiara Pozzi, Daniele Braga, et al.
Diagnostic Pathology|January 22, 2016
Usefulness of pT1 substaging in papillary urothelial bladder carcinomaCarlo Patriarca, Rodolfo Hurle, Marco Moschini, et al.
Therapeutic Advances in Urology|April 2, 2016
Managing chronic bladder diseases with the administration of exogenous glycosaminoglycans: an update on the evidenceMassimo Lazzeri, Rodolfo Hurle, Paolo Casale, et al.
Urologic Oncology|June 29, 2021
The use of 29 MHz transrectal micro-ultrasound to stratify the prostate cancer risk in patients with PI-RADS III lesions at multiparametric MRI: A single institutional analysisPier Paolo Avolio, Giovanni Lughezzani, Marco Paciotti, et al.
European Urology Focus|October 18, 2020
Diagnostic Accuracy of Microultrasound in Patients with a Suspicion of Prostate Cancer at Magnetic Resonance Imaging: A Single-institutional Prospective StudyGiovanni Lughezzani, Davide Maffei, Alberto Saita, et al.
The Journal of Urology|September 30, 2014
Olfactory system of highly trained dogs detects prostate cancer in urine samplesGianluigi Taverna, Lorenzo Tidu, Fabio Grizzi, et al.
World Journal of Urology|January 10, 2022
Use of high-resolution micro-ultrasound to predict extraprostatic extension of prostate cancer prior to surgery: a prospective single-institutional studyVittorio Fasulo, Nicolò Maria Buffi, Federica Regis, et al.
Minerva Urology and Nephrology|September 2, 2025
The current role of photodynamic diagnosis (PDD) in the management of non-muscle invasive bladder cancer: the Italian Society of Urology (SIU) Position PaperFrancesco Soria, Andrea Mari, Marco Moschini, et al.
Pageof 19